116 related articles for article (PubMed ID: 7031858)
1. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
Hansson HB; Barkenius G; Cronberg S; Juhlin I
Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
[TBL] [Abstract][Full Text] [Related]
2. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
Salam MA; Bennish ML
J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
Haltalin KC; Nelson JD; Kusmiesz HT
Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
[TBL] [Abstract][Full Text] [Related]
6. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
Cheasty T; Day M; Threlfall EJ
Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
[TBL] [Abstract][Full Text] [Related]
8. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
Mahmood A
J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
[No Abstract] [Full Text] [Related]
9. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
[TBL] [Abstract][Full Text] [Related]
10. Nalidixic acid for shigellosis.
McCormack JG
Lancet; 1983 Nov; 2(8358):1091. PubMed ID: 6138641
[No Abstract] [Full Text] [Related]
11. Nalidixic acid for shigellosis.
Parry HE
Lancet; 1983 Nov; 2(8360):1206. PubMed ID: 6139566
[No Abstract] [Full Text] [Related]
12. Lactulose therapy in Shigella carrier state and acute dysentery.
Levine MM; Hornick RB
Antimicrob Agents Chemother; 1975 Nov; 8(5):581-4. PubMed ID: 2098
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial of norfloxacin for shigellosis.
Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
[TBL] [Abstract][Full Text] [Related]
14. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
[TBL] [Abstract][Full Text] [Related]
15. Nalidixic acid in Shigella dysenteriae outbreaks.
Malengreau M
Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
[No Abstract] [Full Text] [Related]
16. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
Datta P; Sen D
Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
[TBL] [Abstract][Full Text] [Related]
17. Nalidixic-acid-resistant Shigella dysenteriae I.
Panhotra BR; Desai B; Sharma PL
Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
[No Abstract] [Full Text] [Related]
18. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
[TBL] [Abstract][Full Text] [Related]
19. Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it.
Islam MR; Alam AN; Hussain MS; Mahalanabis D
J Trop Med Hyg; 1995 Apr; 98(2):121-5. PubMed ID: 7714935
[TBL] [Abstract][Full Text] [Related]
20. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
Karas JA; Pillay DG
S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
[No Abstract] [Full Text] [Related]
[Next] [New Search]